Meyka Pro banner
GRAIL, Inc. Common Stock

GRAIL, Inc. Common Stock (GRALV) Stock Overview

Explore GRAIL, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

GRALVNASDAQ
HealthcareMedical - Diagnostics & Research
$18.63
$1.41(8.19%)
U.S. Market opens in 13h 58m

GRAIL, Inc. Common Stock (GRALV)

Meyka AI Score

Z

Key Financials

Market Cap579.4M
P/E RatioN/A
EPS (TTM)N/A
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

GRALV Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of GRAIL, Inc. Common Stock (NASDAQ: GRALV) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, GRAIL, Inc. Common Stock's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of GRALV on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind GRAIL, Inc. Common Stock's NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 579.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of GRALV on the NASDAQ.

Price Performance (NASDAQ: GRALV)

1-Day Change
N/A
5-Day Change
6.52%
1-Month Change
N/A
3-Month Change
186299900.00%
6-Month Change
186299900.00%
Year-to-Date (YTD) Change
186299900.00%
1-Year Change
186299900.00%
3-Year Change
186299900.00%
5-Year Change
186299900.00%
All-Time (Max) Change
186299900.00%

Contact Information

833-694-2553
1525 O’Brien Drive, Menlo Park, CA, 94025

Company Facts

CountryUS

Frequently Asked Questions